Sunday, November 17, 2019
Breaking Medical Device Industry News
Home Compugen Ltd.

Compugen Ltd.

    Compugen Announces FDA Clearance of IND Application for COM902

    "IND clearance for COM902 is an important milestone that marks the third program based on new drug targets we discovered to be evaluated in the clinic," said Anat Cohen-Dayag, Ph.D., President, and CEO of Compugen.

    RECENT COMMENTS